INNO-220

N/A

Report date: 2025/04/21 11:21:45
NME

Base Information

Drug NameINNO-220
Drug Alias NameINNO-220
ClassificationSmall molecules > Molecular Glue
Mechanisms of ActionCasein kinase I isoform alpha degraders
TargetsCasein kinase I isoform alpha
Therapy Area/IndicationsLymphoma, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesInnovo Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesInnovo Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsLymphoma, B-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A